Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.
Clinical trial NCT01494610 · COMPLETED
Trial details
- NCT number
- NCT01494610
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-25
- Primary completion
- 2011-06-08
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.